Artificial intelligence (AI) software developer Annalise.ai has named Lakshmi Gudapakkam as CEO and Dr. Rick Abramson as chief medical officer.
Gudapakkam comes to Annalise.ai with more than 20 years of leadership experience at companies such as GE Healthcare and Philips. In the past four years, he has served as vice president and general manager for the east region at Quest Diagnostics.
A board-certified radiologist, Abramson was previously corporate vice president for the radiology service line at HCA Healthcare. Both executives will be based in the U.S. and are expected to drive the company's expansion into the U.S., according to the firm.
In March, Annalise.ai received U.S. Food and Drug Administration (FDA) clearance for its Enterprise CXR software, which is designed for use in triage and notification of pneumothorax and tension pneumothorax on chest x-rays.
![Representative example of a 16-year-old male patient with underlying X-linked adrenoleukodystrophy. (A, B) Paired anteroposterior (AP) chest radiograph and dual-energy x-ray absorptiometry (DXA) report shows lumbar spine (L1 through L4) areal bone mineral density (BMD). The DXA report was reformatted for anonymization and improved readability. The patient had low BMD (Z score ≤ −2.0). (C) Model (chest radiography [CXR]–BMD) output shows the predicted raw BMD and Z score in comparison with the DXA reference standard, together with interpretability analyses using Shapley additive explanations (SHAP) and gradient-weighted class activation maps. The patient was classified as having low BMD, consistent with the reference standard. AM = age-matched, DEXA = dual-energy x-ray absorptiometry, RM2 = room 2, SNUH = Seoul National University Hospital, YA = young adult.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/ai-children-bone-density.0snnf2EJjr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
